Jeffrey Kindler

Active Investor

Chief Executive Officer at Centrexion Therapeutics Corp.

New York City, New York

Jeffrey Kindler, Chief Executive Officer at Centrexion Therapeutics Corp. is an active investor based in New York City, New York. This profile covers what Jeffrey Kindler backs, at which stage, and how founders can reach out in 2026.

Investor type: AngelInvestment Partner
Stages: Pre SeedSeedSeries ASeries B
Invests in: Artificial IntelligenceHealthcare & BiotechBiotech & PharmaSaaS & EnterpriseHardware & Deep TechRobotics & AutomationIoT & Connected Devices
Location: New York City, New York
Typical check: $625K
Past investments: 2

Notable investments

OpenTronsBlackstone

How to reach Jeffrey Kindler

Angels and operators like Jeffrey Kindler reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.

Frequently Asked Questions

What does Jeffrey Kindler invest in?

Jeffrey Kindler invests in Artificial Intelligence, Healthcare & Biotech, Biotech & Pharma and SaaS & Enterprise, typically at Pre Seed, Seed, Series A and Series B. Match your sector and stage, then reach out with a personalized pitch.